, a global leader in life science analytical technologies, today announced a global initiative focused on biologics. This new initiative is in response to the fundamental shift of the pharmaceutical ...
AB SCIEX, a global leader in analytical technologies, today unveiled three new solutions for biological researchers to improve identification and quantitation of proteins, peptides, metabolites and ...
Indian firm’s mass spec division goes to AB Sciex, and Leica gets the microscopy and histopathology segment. India-based Labindia Instruments is selling its mass spectrometry business to AB Sciex and ...
This collaboration is part of AB SCIEX’s new Academic Partnership Program, which helps support academic researchers to push the limits of biomedical research. The agreement provides AB SCIEX, a global ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX is ranked #1 in the mass spectrometry technology industry once again, according to an independent market research firm that tracks revenues and unit sales ...
AB Sciex is entering the field of in vitro diagnostics with two devices that can be used to analyze trace levels of multiple compounds in human samples: the AB Sciex API 3200MD™ and 3200MD QTRAP® ...
FOSTER CITY, Calif. & CONCORD, Ontario--(BUSINESS WIRE)--AB SCIEX today launched as a new company dedicated to life science analytical technologies. The new company combines the two halves of the ...
Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory (ORNL) ...
Two Central Massachusetts firms – AB SCIEX of Framingham and AbiSee of Acton – have announced partnerships with out-of-state companies to expand their product offerings. AB SCIEX signed an agreement ...
Instrument maker AB Sciex and separations technology firm Phenomenex will jointly develop analytical methods for testing food. The companies hope to create rapid-response approaches that can prevent ...
AB SCIEX has announced a global initiative focused on biologics. This new initiative is in response to the fundamental shift of the pharmaceutical industry into biopharmaceutical development. AB SCIEX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results